| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/08/1997 | US5645997 Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies |
| 07/08/1997 | US5645983 Elisa, antibody-antigen complex |
| 07/08/1997 | US5645836 Toxin conjugated to monoclonal antibody, then crosslinked, reverse transcriptase inhibitor |
| 07/08/1997 | US5645835 Therapeutic antibody based fusion proteins |
| 07/08/1997 | US5645820 Treatment of autoimmune diseases by aerosol administration of autoantigens |
| 07/08/1997 | US5645817 Granulocyte-binding antibody constructs, their preparation and use |
| 07/05/1997 | CA2194411A1 Staphylococcus aureus polynucleotides and sequences |
| 07/03/1997 | WO1997023626A1 Helicobacter pylori oxidoreductase enzymes and their uses |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023623A1 Component of a staphylococcus signal transduction system |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023621A1 Component of a staphylococcus signal transduction system |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023619A1 Sequences coding for new bacteriocins |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023607A2 Presentation of antigen, introduced into cells by stimulation of macropinocytosis |
| 07/03/1997 | WO1997023600A1 A conjugate vaccine against gram-negative bacterial infections |
| 07/03/1997 | WO1997023510A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023506A1 Two-component signal tranducing system from staphylococcus aureus |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
| 07/03/1997 | WO1997023503A1 Vaccine component |
| 07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
| 07/03/1997 | WO1997023243A1 Branched hydrazone linkers |
| 07/03/1997 | WO1997023239A1 Dry compositions |
| 07/03/1997 | WO1997023238A1 Stabilisers for live vaccines |
| 07/03/1997 | WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2241023A1 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/02/1997 | EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production |
| 07/02/1997 | EP0781778A1 Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 07/02/1997 | EP0781560A1 Use of immunoglobulin preparations for the production of a drug for oral administration for treatment and prophylaxis of chronic pain conditions |
| 07/02/1997 | EP0781559A2 Oil adjuvant vaccine and method for preparing same |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/02/1997 | EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 07/02/1997 | EP0781336A1 A human map kinase homolog |
| 07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 07/02/1997 | EP0781296A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
| 07/02/1997 | EP0781144A1 Pharmaceutical compositions containing d 2?o |
| 07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
| 07/02/1997 | EP0781124A1 Active agent transport systems |
| 07/02/1997 | CN1153531A Expression of heterologous proteins in attenuated bacteria using HTRA-promoters |
| 07/02/1997 | CN1153530A Rheumatoid arthritis-related virus MSRV-1 and pathogenic and/or infective agent MSRV-2 |
| 07/02/1997 | CN1153529A Hepatitis G virus and molecular cloning thereof |
| 07/02/1997 | CN1153064A Adjuvants for viral vaccines |
| 07/02/1997 | CN1153063A Method of recovering immunoglobulin from fractions produced during fractionation of human blood plasma |
| 07/02/1997 | CN1153002A Immune milk with anti human body G-I tract pathogenic microorganism function |
| 07/01/1997 | US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 07/01/1997 | US5644036 Purified immunoglobulin |
| 07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
| 07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| 07/01/1997 | US5643957 Compounds and compositions for delivering active agents |
| 07/01/1997 | US5643868 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/01/1997 | US5643786 Method for isolating dendritic cells |
| 07/01/1997 | US5643771 Non-reverting live bacterial vaccines |
| 07/01/1997 | US5643759 Hybridoma cell lines |
| 07/01/1997 | US5643754 Nucleic acids encoding a leptospira outer membrane protein |
| 07/01/1997 | US5643753 Use of autologous promoters to express gene products in bordetella |
| 07/01/1997 | US5643737 Merozoite proteins for use in detection of Babesia equi in horses using immunological techniques |
| 07/01/1997 | US5643732 Immunological assay methods |
| 07/01/1997 | US5643725 Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable haemophilus influenzae |
| 07/01/1997 | US5643715 Human papillomavirus type 52 DNA sequences and methods for employing the same |
| 07/01/1997 | US5643714 Method and assay for HTLV |
| 07/01/1997 | US5643605 Polylactide or polylactide-glycolide copolymer |
| 07/01/1997 | US5643579 Producing antibodies or cell mediated immunity to adenovirus |
| 07/01/1997 | US5643578 Subunit vaccines |
| 07/01/1997 | US5643577 Oral vaccine comprising antigen surface-associated with red blood cells |
| 07/01/1997 | US5643576 Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen |
| 07/01/1997 | US5643574 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/01/1997 | US5643573 Drug delivery |
| 07/01/1997 | US5643572 Monoclonal antibody to urushiol |
| 07/01/1997 | US5643565 Human IL-2 as a vaccine adjuvant |
| 07/01/1997 | CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 06/26/1997 | WO1997022880A1 Use of rc-9 in diagnosis and treatment of proliferative arterial disease |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022688A1 Heterophil-adapted poultry vaccine |
| 06/26/1997 | WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 06/26/1997 | WO1997022349A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 06/26/1997 | WO1997022333A1 Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles |
| 06/26/1997 | WO1997022255A1 p62 POLYPEPTIDES, RELATED POLYPEPTIDES, AND USES THEREFOR |
| 06/26/1997 | WO1997022248A1 Composition for organ cryopreservation and treatment of viral and bacterial infections |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | DE19547324A1 cDNA encoding human mucin 8 |
| 06/26/1997 | CA2240829A1 Heterophil-adapted poultry vaccine |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2240131A1 Composition for organ cryopreservation and treatment of viral and bacterial infections |
| 06/25/1997 | EP0780475A1 CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
| 06/25/1997 | EP0779924A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 06/25/1997 | EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases |